Metsafe 1000 ER Tablet, Film-coated 1000 mg Tanzania - English - Tanzania Medicinces & Medical Devices Authority

metsafe 1000 er tablet, film-coated 1000 mg

msn laboratories private limited , india - metformin - tablet, film-coated - 1000 mg

EFFISAR 40 Tablet, Film-coated 40 mg/tablet Tanzania - English - Tanzania Medicinces & Medical Devices Authority

effisar 40 tablet, film-coated 40 mg/tablet

msn laboratories private limited , india - olmesartan medoxil - tablet, film-coated - 40 mg/tablet

EFFISAR 20 Tablet, Film-coated 20 mg Tanzania - English - Tanzania Medicinces & Medical Devices Authority

effisar 20 tablet, film-coated 20 mg

msn laboratories private limited , india - olmesartan medoxomil - tablet, film-coated - 20 mg

METSAFE 500 ER Extended Release Tablet 500 mg Tanzania - English - Tanzania Medicinces & Medical Devices Authority

metsafe 500 er extended release tablet 500 mg

msn laboratories private limited , india - metformin hydrochloride - extended release tablet - 500 mg

SILMELT 100 Tablets Tanzania - English - Tanzania Medicinces & Medical Devices Authority

silmelt 100 tablets

msn laboratories private limited , india - sildenafil citrate - tablets - 100

Cosamide 100 Tablet, Film-coated Tanzania - English - Tanzania Medicinces & Medical Devices Authority

cosamide 100 tablet, film-coated

msn laboratories private limited , india - lacosamide - tablet, film-coated - 100

Cosamide 50 Tablets Tanzania - English - Tanzania Medicinces & Medical Devices Authority

cosamide 50 tablets

msn laboratories private limited , india - lacosamide - tablets - 50

Plasep Tablet, Film-coated 75 mg Tanzania - English - Tanzania Medicinces & Medical Devices Authority

plasep tablet, film-coated 75 mg

msn laboratories private limited , india - clopidogrel - tablet, film-coated - 75 mg

PREGABALIN tablet, film coated, extended release United States - English - NLM (National Library of Medicine)

pregabalin tablet, film coated, extended release

msn laboratories private limited - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin extended-release tablets are indicated for the management of: -  neuropathic pain associated with diabetic peripheral neuropathy - postherpetic neuralgia efficacy of pregabalin extended-release tablets has not been established for the management of fibromyalgia or as adjunctive therapy for adult patients with partial onset seizures. pregabalin extended-release tablets is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [ see warnings and precautions (5.1, 5.2),adverse reactions (6)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information regarding the effects of in utero exposure to pregabalin extended-release tablets, physicians are advised to recommend that pregnant patients taking pregabalin extended-release tablets enroll in the nort

PREGABALIN capsule United States - English - NLM (National Library of Medicine)

pregabalin capsule

msn laboratories private limited - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin capsule is indicated for: - management of neuropathic pain associated with diabetic peripheral neuropathy - management of postherpetic neuralgia - adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older -  management of fibromyalgia - management of neuropathic pain associated with spinal cord injury pediatric use information is approved for pfizer's lyrica (pregabalin) capsules and oral  solution products. however, due to pfizer's marketing exclusivity rights, this drug product  is not labeled with that pediatric information. pregabalin is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information regarding the